Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Senores Pharmaceuticals Limited (NSE: SENORES), ISIN INE0RB801010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SENORES last traded at ₹1383.40 (+0.25%), with a 52-week range of ₹661.65 to ₹1599.55 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 45.82%, FIIs 6.62%, DIIs 9.77%, mutual funds 6.56%.
EquiSense Score (ECS): 88/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.